{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:30:48Z","timestamp":1782984648571,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172003"],"award-info":[{"award-number":["82172003"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82222033"],"award-info":[{"award-number":["82222033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130059"],"award-info":[{"award-number":["82130059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fundamental Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.fmre.2025.02.004","type":"journal-article","created":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:44:41Z","timestamp":1748832281000},"page":"1911-1919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal delivery of rotigotine to the brain for treating Parkinson\u2019s disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Dandan","family":"Kou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7654-8724","authenticated-orcid":false,"given":"Jianfeng","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fmre.2025.02.004_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2021.101328","article-title":"Nanomaterials as novel agents for amelioration of Parkinson\u2019s disease","volume":"41","author":"Wu","year":"2021","journal-title":"Nano Today"},{"issue":"5","key":"10.1016\/j.fmre.2025.02.004_bib0002","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.fmre.2025.02.004_bib0003","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7628","key":"10.1016\/j.fmre.2025.02.004_bib0004","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/539179a","article-title":"Neurodegenerative diseases","volume":"539","author":"Heemels","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.fmre.2025.02.004_bib0005","article-title":"Glial cell crosstalk in Parkinson\u2019s Disease: Mechanisms, implications, and therapeutic strategies","author":"Wang","year":"2025","journal-title":"Fundamental Research"},{"issue":"1","key":"10.1016\/j.fmre.2025.02.004_bib0006","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1474-4422(21)00330-6","article-title":"The neuropsychiatry of Parkinson's disease: Advances and challenges","volume":"21","author":"Weintraub","year":"2022","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.fmre.2025.02.004_bib0007","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lfs.2019.03.057","article-title":"Parkinson's disease: Mechanisms, translational models and management strategies","volume":"226","author":"Raza","year":"2019","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.fmre.2025.02.004_bib0008","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson's disease treatment: Past, present, and future","volume":"127","author":"Elsworth","year":"2020","journal-title":"J. Neural. Transm."},{"issue":"8","key":"10.1016\/j.fmre.2025.02.004_bib0009","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: Etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"8","key":"10.1016\/j.fmre.2025.02.004_bib0010","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40265-020-01307-x","article-title":"Levodopa inhalation powder: A review in Parkinson's disease","volume":"80","author":"Paik","year":"2020","journal-title":"Drugs"},{"issue":"6","key":"10.1016\/j.fmre.2025.02.004_bib0011","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-023-02647-0","article-title":"Role of dopamine agonists in Parkinson's disease therapy","volume":"130","author":"Woitalla","year":"2023","journal-title":"J. Neural. Transm."},{"issue":"9","key":"10.1016\/j.fmre.2025.02.004_bib0012","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037632","article-title":"Diagnosis, treatment and management of apathy in Parkinson's disease: A scoping review","volume":"10","author":"Mele","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.fmre.2025.02.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.122197","article-title":"Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation","volume":"338","author":"Park","year":"2024","journal-title":"Carbohydr. Polym."},{"issue":"7","key":"10.1016\/j.fmre.2025.02.004_bib0014","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s40263-019-00646-y","article-title":"Rotigotine transdermal patch: A review in Parkinson's disease","volume":"33","author":"Frampton","year":"2019","journal-title":"CNS Drugs"},{"issue":"11","key":"10.1016\/j.fmre.2025.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1517\/17425240802500870","article-title":"Crystallisation within transdermal rotigotine patch: Is there cause for concern?","volume":"5","author":"Chaudhuri","year":"2008","journal-title":"Expert Opin. Drug Del."},{"issue":"46","key":"10.1016\/j.fmre.2025.02.004_bib0016","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201801362","article-title":"Overcoming the blood-brain barrier: The role of nanomaterials in treating neurological diseases","volume":"30","author":"Furtado","year":"2018","journal-title":"Adv. Mater."},{"issue":"11","key":"10.1016\/j.fmre.2025.02.004_bib0017","doi-asserted-by":"crossref","first-page":"18327","DOI":"10.1021\/acsnano.1c07587","article-title":"A microfluidics-based scalable approach to generate extracellular vesicles with enhanced therapeutic MicroRNA loading for intranasal delivery to mouse glioblastomas","volume":"15","author":"Wang","year":"2021","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.fmre.2025.02.004_bib0018","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","article-title":"Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies","volume":"11","author":"Costa","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"3","key":"10.1016\/j.fmre.2025.02.004_bib0019","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0963689718754561","article-title":"The route by which intranasally delivered stem cells enter the Central nervous system","volume":"27","author":"Galeano","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/j.fmre.2025.02.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202470093","article-title":"Lipid and transcriptional regulation in a Parkinson's Disease mouse model by intranasal vesicular and hexosomal plasmalogen-based nanomedicines","volume":"13","author":"Wu","year":"2024","journal-title":"Adv. Healthc. Mater."},{"issue":"23","key":"10.1016\/j.fmre.2025.02.004_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313042","article-title":"Targeting ferroptosis in Parkinson\u2019s Disease: Mechanisms and emerging therapeutic strategies","volume":"25","author":"Zhou","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.fmre.2025.02.004_bib0022","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jconrel.2017.09.001","article-title":"Progress in brain targeting drug delivery system by nasal route","volume":"268","author":"Khan","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.fmre.2025.02.004_bib0023","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1021\/acs.nanolett.2c05056","article-title":"Intranasal pathway for nanoparticles to enter the Central nervous system","volume":"23","author":"Kou","year":"2023","journal-title":"Nano Lett"},{"issue":"6","key":"10.1016\/j.fmre.2025.02.004_bib0024","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jps.2600840609","article-title":"Effect of surfactants on the physical stability of recombinant Human hormone","volume":"84","author":"Katakam","year":"1995","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.fmre.2025.02.004_bib0025","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/js960097g","article-title":"Controlled-release delivery system for the \u03b1-MSH Analog Melanotan-I using Poloxamer 407","volume":"85","author":"Blanchard","year":"1996","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.fmre.2025.02.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202108146","article-title":"Achieving efficient NIR-II type-I photosensitizers for photodynamic\/photothermal therapy upon regulating chalcogen elements","volume":"34","author":"Wen","year":"2021","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.fmre.2025.02.004_bib0027","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejpb.2008.09.021","article-title":"Engineered polymers for advanced drug delivery","volume":"71","author":"Kim","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.fmre.2025.02.004_bib0028","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.2147\/IJN.S120939","article-title":"Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson's disease treatment","volume":"11","author":"Bi","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"1","key":"10.1016\/j.fmre.2025.02.004_bib0029","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1080\/10717544.2017.1359862","article-title":"Nanotechnology-based drug delivery of ropinirole for Parkinson's disease","volume":"24","author":"Barcia","year":"2017","journal-title":"Drug Deliv"},{"issue":"9","key":"10.1016\/j.fmre.2025.02.004_bib0030","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004555","article-title":"Trojan horse delivery of 4,4\u2032-dimethoxychalcone for parkinsonian neuroprotection","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.fmre.2025.02.004_bib0031","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.actbio.2020.10.031","article-title":"Advanced materials for drug delivery across mucosal barriers","volume":"119","author":"Bandi","year":"2021","journal-title":"Acta Biomater"},{"key":"10.1016\/j.fmre.2025.02.004_bib0032","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.addr.2017.08.010","article-title":"PEGylation for enhancing nanoparticle diffusion in mucus","volume":"124","author":"Huckaby","year":"2018","journal-title":"Adv. Drug Deliv."},{"key":"10.1016\/j.fmre.2025.02.004_bib0033","doi-asserted-by":"crossref","first-page":"23014","DOI":"10.1021\/acsnano.4c04674","article-title":"Engineered extracellular vesicle-based nanoformulations that coordinate neuroinflammation and immune homeostasis, enhancing Parkinson's Disease therapy","volume":"18","author":"Zhang","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.fmre.2025.02.004_bib0034","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/pharmaceutics15030851","article-title":"Self-assembled Lecithin-Chitosan nanoparticles improved rotigotine nose-to-brain delivery and brain targeting efficiency","volume":"15","author":"Saha","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.fmre.2025.02.004_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119148","article-title":"Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease","volume":"579","author":"Bhattamisra","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.fmre.2025.02.004_bib0036","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/pharmaceutics11010026","article-title":"Fabrication, optimization, and evaluation of rotigotine-loaded chitosan nanoparticles for nose-to-brain delivery","volume":"11","author":"Tzeyung","year":"2019","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.fmre.2025.02.004_bib0037","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"8","key":"10.1016\/j.fmre.2025.02.004_bib0038","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.3390\/ijms23084176","article-title":"Neuromelanin in Parkinson's Disease: Tyrosine hydroxylase and tyrosinase","volume":"23","author":"Nagatsu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"52","key":"10.1016\/j.fmre.2025.02.004_bib0039","doi-asserted-by":"crossref","first-page":"21730","DOI":"10.1021\/jacs.0c09390","article-title":"Targeting microglia for therapy of Parkinson's disease by using biomimetic ultrasmall nanoparticles","volume":"142","author":"Liu","year":"2020","journal-title":"J. Am. Chem. Soc."}],"container-title":["Fundamental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325825000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667325825000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T21:59:10Z","timestamp":1772920750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667325825000871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2667325825000871"],"URL":"https:\/\/doi.org\/10.1016\/j.fmre.2025.02.004","relation":{},"ISSN":["2667-3258"],"issn-type":[{"value":"2667-3258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of rotigotine to the brain for treating Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Fundamental Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fmre.2025.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}